annual EBIT:
$554.43M+$349.13M(+170.05%)Summary
- As of today (July 1, 2025), BMRN annual earnings before interest & taxes is $554.43 million, with the most recent change of +$349.13 million (+170.05%) on December 31, 2024.
- During the last 3 years, BMRN annual EBIT has risen by +$615.03 million (+1014.81%).
- BMRN annual EBIT is now at all-time high.
Performance
BMRN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$240.95M+$69.06M(+40.18%)Summary
- As of today (July 1, 2025), BMRN quarterly earnings before interest & taxes is $240.95 million, with the most recent change of +$69.06 million (+40.18%) on March 31, 2025.
- Over the past year, BMRN quarterly EBIT has increased by +$131.86 million (+120.87%).
- BMRN quarterly EBIT is now at all-time high.
Performance
BMRN quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$685.96M+$131.86M(+23.80%)Summary
- As of today (July 1, 2025), BMRN TTM earnings before interest & taxes is $685.96 million, with the most recent change of +$131.86 million (+23.80%) on March 31, 2025.
- Over the past year, BMRN TTM EBIT has increased by +$434.94 million (+173.27%).
- BMRN TTM EBIT is now at all-time high.
Performance
BMRN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BMRN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +170.1% | +120.9% | +173.3% |
| 3 y3 years | +1014.8% | +74.6% | +1262.3% |
| 5 y5 years | +855.5% | +122.5% | +742.7% |
BMRN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1014.8% | at high | +1597.7% | at high | +864.9% |
| 5 y | 5-year | at high | +855.5% | at high | +480.5% | at high | +764.2% |
| alltime | all time | at high | +169.8% | at high | +142.0% | at high | +186.3% |
BMRN EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $240.95M(+40.2%) | $685.96M(+23.8%) |
| Dec 2024 | $554.43M(+170.1%) | $171.89M(+25.1%) | $554.10M(+37.1%) |
| Sep 2024 | - | $137.41M(+1.3%) | $404.13M(+29.5%) |
| Jun 2024 | - | $135.71M(+24.4%) | $312.17M(+24.4%) |
| Mar 2024 | - | $109.09M(+397.8%) | $251.02M(+24.0%) |
| Dec 2023 | $205.30M(+24.5%) | $21.91M(-51.8%) | $202.39M(+23.1%) |
| Sep 2023 | - | $45.45M(-39.0%) | $164.38M(+35.1%) |
| Jun 2023 | - | $74.56M(+23.3%) | $121.71M(+41.8%) |
| Mar 2023 | - | $60.46M(-475.8%) | $85.86M(-47.5%) |
| Dec 2022 | $164.95M(-372.2%) | -$16.09M(-679.7%) | $163.39M(+40.7%) |
| Sep 2022 | - | $2.77M(-92.8%) | $116.16M(+63.4%) |
| Jun 2022 | - | $38.71M(-71.9%) | $71.09M(+41.2%) |
| Mar 2022 | - | $137.99M(-317.9%) | $50.35M(-183.1%) |
| Dec 2021 | -$60.61M(+181.7%) | -$63.32M(+49.7%) | -$60.61M(+47.0%) |
| Sep 2021 | - | -$42.29M(-335.3%) | -$41.23M(-18.5%) |
| Jun 2021 | - | $17.97M(-33.5%) | -$50.55M(-51.0%) |
| Mar 2021 | - | $27.03M(-161.5%) | -$103.27M(+368.6%) |
| Dec 2020 | -$21.52M(-70.7%) | -$43.94M(-14.9%) | -$22.04M(-229.5%) |
| Sep 2020 | - | -$51.62M(+48.6%) | $17.02M(-79.1%) |
| Jun 2020 | - | -$34.75M(-132.1%) | $81.40M(+1.0%) |
| Mar 2020 | - | $108.27M(-2317.7%) | $80.61M(-209.1%) |
| Dec 2019 | -$73.38M(-25.9%) | -$4.88M(-138.3%) | -$73.89M(-27.2%) |
| Sep 2019 | - | $12.76M(-135.9%) | -$101.56M(-17.2%) |
| Jun 2019 | - | -$35.54M(-23.1%) | -$122.60M(+16.7%) |
| Mar 2019 | - | -$46.23M(+42.0%) | -$105.03M(+6.0%) |
| Dec 2018 | -$99.04M(-3287.7%) | -$32.55M(+292.6%) | -$99.04M(+9359.5%) |
| Sep 2018 | - | -$8.29M(-53.8%) | -$1.05M(-71.2%) |
| Jun 2018 | - | -$17.96M(-55.4%) | -$3.63M(-83.5%) |
| Mar 2018 | - | -$40.25M(-161.5%) | -$22.07M(-810.2%) |
| Dec 2017 | $3.11M(-100.4%) | $65.45M(-701.8%) | $3.11M(-102.1%) |
| Sep 2017 | - | -$10.88M(-70.1%) | -$145.66M(-24.3%) |
| Jun 2017 | - | -$36.39M(+141.4%) | -$192.45M(-73.6%) |
| Mar 2017 | - | -$15.07M(-81.9%) | -$729.88M(-8.2%) |
| Dec 2016 | -$794.92M(+563.7%) | -$83.33M(+44.5%) | -$794.92M(+30.3%) |
| Sep 2016 | - | -$57.66M(-90.0%) | -$610.12M(-3.8%) |
| Jun 2016 | - | -$573.83M(+616.3%) | -$634.28M(+374.0%) |
| Mar 2016 | - | -$80.11M(-178.9%) | -$133.81M(+11.7%) |
| Dec 2015 | -$119.77M(+30.8%) | $101.47M(-224.0%) | -$119.77M(-57.0%) |
| Sep 2015 | - | -$81.82M(+11.5%) | -$278.62M(+50.4%) |
| Jun 2015 | - | -$73.36M(+11.0%) | -$185.29M(+41.2%) |
| Mar 2015 | - | -$66.07M(+15.2%) | -$131.26M(+43.4%) |
| Dec 2014 | -$91.56M(-45.2%) | -$57.37M(-598.4%) | -$91.56M(+5.6%) |
| Sep 2014 | - | $11.51M(-159.5%) | -$86.70M(-42.2%) |
| Jun 2014 | - | -$19.34M(-26.6%) | -$150.06M(-0.3%) |
| Mar 2014 | - | -$26.36M(-49.8%) | -$150.48M(-10.0%) |
| Dec 2013 | -$167.13M(+49.8%) | -$52.51M(+1.3%) | -$167.13M(+2.1%) |
| Sep 2013 | - | -$51.85M(+162.4%) | -$163.75M(+34.4%) |
| Jun 2013 | - | -$19.76M(-54.1%) | -$121.82M(-8.1%) |
| Mar 2013 | - | -$43.01M(-12.4%) | -$132.55M(+18.8%) |
| Dec 2012 | -$111.60M(+216.9%) | -$49.12M(+395.0%) | -$111.60M(+33.3%) |
| Sep 2012 | - | -$9.92M(-67.5%) | -$83.71M(-8.4%) |
| Jun 2012 | - | -$30.49M(+38.2%) | -$91.35M(+52.7%) |
| Mar 2012 | - | -$22.06M(+3.9%) | -$59.83M(+69.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$35.22M(+230.0%) | -$21.24M(+20.9%) | -$35.22M(+15.6%) |
| Sep 2011 | - | -$17.56M(-1808.5%) | -$30.47M(+109.9%) |
| Jun 2011 | - | $1.03M(-59.8%) | -$14.52M(+17.7%) |
| Mar 2011 | - | $2.56M(-115.5%) | -$12.33M(+15.6%) |
| Dec 2010 | -$10.67M(-172.8%) | -$16.49M(+924.3%) | -$10.67M(-186.0%) |
| Sep 2010 | - | -$1.61M(-150.1%) | $12.42M(-49.3%) |
| Jun 2010 | - | $3.21M(-23.8%) | $24.49M(-11.0%) |
| Mar 2010 | - | $4.22M(-36.1%) | $27.52M(+87.8%) |
| Dec 2009 | $14.66M(-70.6%) | $6.60M(-37.0%) | $14.65M(-62.1%) |
| Sep 2009 | - | $10.46M(+67.8%) | $38.71M(+15.8%) |
| Jun 2009 | - | $6.24M(-172.1%) | $33.43M(-5.1%) |
| Mar 2009 | - | -$8.65M(-128.2%) | $35.23M(-21.2%) |
| Dec 2008 | $49.82M(-187.0%) | $30.65M(+491.1%) | $44.70M(+988.7%) |
| Sep 2008 | - | $5.19M(-35.5%) | $4.11M(-122.3%) |
| Jun 2008 | - | $8.04M(+883.4%) | -$18.39M(-54.1%) |
| Mar 2008 | - | $818.00K(-108.2%) | -$40.03M(-30.5%) |
| Dec 2007 | -$57.29M(+132.2%) | -$9.94M(-42.6%) | -$57.64M(-2.7%) |
| Sep 2007 | - | -$17.31M(+27.3%) | -$59.26M(+28.6%) |
| Jun 2007 | - | -$13.60M(-19.0%) | -$46.07M(+36.3%) |
| Mar 2007 | - | -$16.79M(+45.2%) | -$33.80M(+37.0%) |
| Dec 2006 | -$24.67M(-61.6%) | -$11.56M(+180.9%) | -$24.67M(-4.9%) |
| Sep 2006 | - | -$4.12M(+207.9%) | -$25.94M(-25.9%) |
| Jun 2006 | - | -$1.34M(-82.5%) | -$34.99M(-33.3%) |
| Mar 2006 | - | -$7.66M(-40.3%) | -$52.43M(-18.3%) |
| Dec 2005 | -$64.21M(-56.6%) | -$12.83M(-2.6%) | -$64.21M(-52.4%) |
| Sep 2005 | - | -$13.17M(-29.8%) | -$134.94M(-9.1%) |
| Jun 2005 | - | -$18.77M(-3.4%) | -$148.39M(+0.3%) |
| Mar 2005 | - | -$19.44M(-76.7%) | -$148.02M(+0.1%) |
| Dec 2004 | -$147.91M(+95.1%) | -$83.56M(+213.9%) | -$147.91M(+65.3%) |
| Sep 2004 | - | -$26.62M(+44.7%) | -$89.47M(+7.1%) |
| Jun 2004 | - | -$18.40M(-4.8%) | -$83.52M(+12.0%) |
| Mar 2004 | - | -$19.34M(-23.0%) | -$74.59M(-1.6%) |
| Dec 2003 | -$75.80M(+12.1%) | -$25.11M(+21.5%) | -$75.80M(-1.5%) |
| Sep 2003 | - | -$20.67M(+118.1%) | -$76.94M(+7.9%) |
| Jun 2003 | - | -$9.48M(-53.9%) | -$71.32M(-4.7%) |
| Mar 2003 | - | -$20.54M(-21.7%) | -$74.81M(+10.6%) |
| Dec 2002 | -$67.62M(+42.0%) | -$26.25M(+74.5%) | -$67.62M(+13.4%) |
| Sep 2002 | - | -$15.05M(+16.0%) | -$59.61M(+9.9%) |
| Jun 2002 | - | -$12.97M(-2.8%) | -$54.24M(+5.7%) |
| Mar 2002 | - | -$13.35M(-26.8%) | -$51.29M(+10.6%) |
| Dec 2001 | -$47.63M(+33.5%) | -$18.24M(+88.5%) | -$46.38M(+13.6%) |
| Sep 2001 | - | -$9.67M(-3.6%) | -$40.84M(+3.6%) |
| Jun 2001 | - | -$10.03M(+18.8%) | -$39.42M(+7.8%) |
| Mar 2001 | - | -$8.44M(-33.5%) | -$36.57M(+2.5%) |
| Dec 2000 | -$35.67M(+38.3%) | -$12.70M(+54.0%) | -$35.67M(+17.4%) |
| Sep 2000 | - | -$8.25M(+14.7%) | -$30.38M(+1.5%) |
| Jun 2000 | - | -$7.19M(-4.7%) | -$29.93M(+3.8%) |
| Mar 2000 | - | -$7.54M(+1.9%) | -$28.84M(+11.4%) |
| Dec 1999 | -$25.80M(+100.0%) | -$7.40M(-5.2%) | -$25.88M(+40.0%) |
| Sep 1999 | - | -$7.80M(+27.9%) | -$18.48M(+73.0%) |
| Jun 1999 | - | -$6.10M(+33.1%) | -$10.68M(+133.1%) |
| Mar 1999 | - | -$4.58M | -$4.58M |
| Dec 1998 | -$12.90M | - | - |
FAQ
- What is BioMarin Pharmaceutical annual earnings before interest & taxes?
- What is the all time high annual EBIT for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual EBIT year-on-year change?
- What is BioMarin Pharmaceutical quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly EBIT year-on-year change?
- What is BioMarin Pharmaceutical TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical TTM EBIT year-on-year change?
What is BioMarin Pharmaceutical annual earnings before interest & taxes?
The current annual EBIT of BMRN is $554.43M
What is the all time high annual EBIT for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual earnings before interest & taxes is $554.43M
What is BioMarin Pharmaceutical annual EBIT year-on-year change?
Over the past year, BMRN annual earnings before interest & taxes has changed by +$349.13M (+170.05%)
What is BioMarin Pharmaceutical quarterly earnings before interest & taxes?
The current quarterly EBIT of BMRN is $240.95M
What is the all time high quarterly EBIT for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly earnings before interest & taxes is $240.95M
What is BioMarin Pharmaceutical quarterly EBIT year-on-year change?
Over the past year, BMRN quarterly earnings before interest & taxes has changed by +$131.86M (+120.87%)
What is BioMarin Pharmaceutical TTM earnings before interest & taxes?
The current TTM EBIT of BMRN is $685.96M
What is the all time high TTM EBIT for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high TTM earnings before interest & taxes is $685.96M
What is BioMarin Pharmaceutical TTM EBIT year-on-year change?
Over the past year, BMRN TTM earnings before interest & taxes has changed by +$434.94M (+173.27%)